Abstract
Individually, childhood epilepsy and migraine are two of the most common conditions seen in pediatric neurology. What complicates matters is that there can be marked similarities between migraine and epilepsy as well as a variety of underlying conditions that predispose children to both seizures and headache. Thus, separating epilepsy from migraine may not be easy, but can be done with a detailed history as well as timely use of ancillary testing. Once children have been diagnosed with epilepsy, migraine, or both, treatment options become essential in attempts to manage these common, yet often disabling, neurological conditions. Acute interventions tend to be condition specific while preventative options may overlap for migraine and epilepsy. In the following review, we will discuss the epidemiology of childhood epilepsy and headache, the association between them, as well as how to differentiate epilepsy from migraine. Treatment strategies will follow before concluding with a discussion on prognosis.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of outstanding importance
Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: Focus on epilepsy and migraine. Lancet Neurol. 2006;5:148–57.
Kelley SA, Hartman AL, Kossoff EH. Comorbidity of migraine in children presenting with epilepsy to a tertiary care center. Neurology. 2012;79:468–73. Recent prospective clinical study that correlates with other recent reports that there is a greater comorbidity between epilepsy and headache/migraine than previously indicated.
Winawer MR, Connors R, EPGP Investigators. Evidence for a shared genetic susceptibility to migraine and epilepsy. Epilepsia. 2013;54(2):288–95. Recent cross section multicenter study of a known cohort of epilepsy patients that demonstrated higher prevalence of migraine than historical reports. Results similar to other recent reports with higher than previously noted rates of migraine in pediatric epilepsy patients. Suggesting a greater association between migraine and epilepsy than previously thought.
Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52:1088–97.
Hershey AD. Perimenstrual headache in adolescence. Curr Pain Headache Rep. 2012;16(5):474–6.
Sillanpää M, Saarinen M, Schmidt D. Long-term risks following first remission in childhood-onset epilepsy. A population-based study. Epilepsy Behav. 2012;25(2):145–9.
Institute of Medicine. Epilepsy across the spectrum: promoting health and understanding. Washington, DC: The National Academy Press; 2012. Available at http://www.iom.edu/epilepsy. *Recent report that indicates epilepsy more prevalent than previously thought.
Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester. Minn Epilepsia. 1991;32:429–45.
Shorvon SD, Goodridge DM Longitudinal cohort studies of the prognosis of epilepsy: contribution of the National General Practice Study of Epilepsy and other studies. Brain. 2013 Sep 24.
Theodore WH, Spencer SS, Wiebe S, et al. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia. 2006;47:1700–22.
Deubner DC. An epidemiologic study of migraine and headache in 10–20 year olds. Headache. 1977;17:173–80.
Sillanpaa M. Changes in the prevalence of migraine and other headache during the first seven school years. Headache. 1983;23:15–9.
Liner MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261:2211–6.
Stewart WF, Linet MS, Celentano DD, Van Natta M, Siegler D. Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991;34:1111–20.
Sillanpaa M. Prevalence of headache in prepuberty. Headache. 1983;23:10–4.
Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309(6957):765–9.
Dalsgaard-Nielsen T. Some aspects of the epidemiology of migraine in Denmark. Headache. 1970;10:14–23.
Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994;34:319–28.
Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, Vahlquist and IHS criteria. Dev Med Child Neurol. 1992;34:1095–101.
Valquist B. Migraine in children. Int Arch Allergy. 1955;7:348–55.
Small P, Waters WE. Headache and migraine in a comprehensive school. In: Waters, editor. The epidemiology of migraine. Bracknell-Berkshire, England: Boehringer Ingel-helm, Ltd; 1974. p. 56–67.
Sillanpaa M. Prevalence of migraine and other headache in Finnish children starting school. Headache. 1976;15:288–90.
Lewis DW, Ashwal S, Dahl G, Dorbad D, Hirtz D, Prensky A, et al. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002;59(4):490–8.
Dalsgaard-Nielsen T. Some aspects of the epidemiology of migraine in Denmark. Headache. 1970;10:14–23.
Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache. 2007;47:355–63.
Stewart WF, Wood C, Reed ML, Roy J, Lipton RB. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008;28:1170–8.
Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. Pediatrics. 2003;112(1 Pt 1):e1–5.
Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache. 2008;48:553–63.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676–85.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
Andermann E, Andermann F. Migraine-epilepsy relationships: Epidemiological and genetic aspects. In: Andermann FA, Lugaresi E, editors. Migraine and Epilepsy. Boston: Butterworths; 1987.
Toldo I, Perissinotto E, Menegazzo F, et al. Comorbidity between headache and epilepsy in a pediatric headache center. J Headache Pain. 2010;11:235–40.
Bigal ME, Lipton RB, Cohen J, et al. Epilepsy and migraine. Epilepsy Behav. 2003;4 suppl 2:S13–24.
Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology. 1994;44:2105–10.
Stevenson SB. Epilepsy and migraine headache: Is there a connection? J Pediatr Health Care. 2005;20:167–71.
Kanemura H, Sano F, Ishii S, Ohyama T, Sugita K, Aihara M. Characteristics of headache in children with epilepsy. Seizure. 2013;22(8):647–50. Recent prospective clinical study that correlates with other recent reports that there is a greater comorbidity between epilepsy and headache/migraine than previously indicated.
Deprez L, Peeters K, Van Paesschen W, Claeys KG, Claes LR, Suls A, et al. Familial occipitotemporal lobe epilepsy and migraine with visual aura: linkage to chromosome 9q. Neurology. 2007;68:1995–2002.
Polvi A, Siren A, Kallela M, Rantala H, Artto V, Sobel EM, et al. Shared loci for migraine and epilepsy on chromosomes 14q12–q23 and 12q24.2–q24.3. Neurology. 2012;78:202–9.
Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, Robertson R, et al. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain. 2004;127:2682–92.
Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366:371–7.
Deprez L, Weckhuysen S, Peeters K, Deconinck T, Claeys KG, Claes LR, et al. Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia. 2008;49:500–8.
Lebas A, Guyant-Maréchal L, Hannequin D, Riant F, Tournier-Lasserve E, Parain D. Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation. Cephalalgia. 2008;28(7):774–7.
Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, An- Gourfinkel I, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet. 2000;24:343–5.
Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68:1327–32.
Frosk P, Mhanni AA, Rafay MF. SCN1A mutation associated with intractable myoclonic epilepsy and migraine headache. J Child Neurol. 2013;28(3):389–91.
Riant F, Ducros A, Ploton C, Banbance C, Depienne C, Tournie-Lasserve E. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology. 2010;75:967–72.
De Fusco M, Marconi R, Silvestri L, et al. Haplo insufficiency of ATP1A2 encoding the Na+/K+ pump a2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33:192–6.
Vanmolkot KR, Kors EE, Hottenga JJ, Terwindt GM, Haan JJ, Hoefnagels WA. Novel mutations in the Na+/K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol. 2003;54:360–6.
Gambardella A, Marini C. Clinical spectrum of SCN1A mutations. Epilepsia. 2009;50:20–3.
Wirrell EC, Hamiwka LD. Do children with benign rolandic epilepsy have a higher prevalence of migraine than those with other partial epilepsies or nonepilepsy controls? Epilepsia. 2006;47:1674–81.
Clarke T, Baskurt Z, Strug L, Pal D. Evidence of shared genetic risk factors for migraine and rolandic epilepsy. Epilepsia. 2009;50:2428–33.
Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain. 2008;131:2264–86.
Covanis A. Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics. 2006;118(4):e1237–43.
Gastaut H. A new type of epilepsy: Benign partial epilepsy of childhood with occipital spike-waves. Clin Electroencephalogr. 1982;13:13–22.
Panayiotopoulos CP. Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: Differentiation from migraine. J Neurol Neurosurg Psychiatry. 1999;57:1371–4.
Giroud M, Couillaut G, Arnould S, et al. Epilepsy with rolandic paroxysms and migraine: A nonfortuitous association. Results of a controlled study. Pediatrie. 1989;44:659–64.
Neut D, Fily A, Cuvellier JC, Vallée L. The prevalence of triggers in pediatric migraine: a questionnaire study in 102 children and adolescents. J Headache Pain. 2012;13(1):61–5.
Balamurugan E, Aggarwal M, Lamba A, Dang N, Tripathi M. Perceived trigger factors of seizures in persons with epilepsy. Seizure. 2013;22(9):743–7.
Parisi P, Piccioli M, Villa MP, et al. Hypothesis on neurophysiopathological mechanisms linking epilepsy and headache. Med Hypotheses. 2008;70:1150–4.
Verrotti A, Coppola G, Spalice A, Di Fonzo A, Bruschi R, Tozzi E, et al. Peri-ictal and inter-ictal headache in children and adolescents with idiopathic epilepsy: a multicenter cross-sectional study. Childs Nerv Syst. 2011;27(9):1419–23.
Lope RJ, Wong SW, Wu LL. Episodic vomiting and headache in children: consider occipital epilepsy. J Paediatr Child Health. 2010;46(4):204–6.
Papatheophilou R, Jeavons PM, Disney ME. Recurrent abdominal pain: a clinical and electroencephalographic study. Dev Med Child Neurol. 1972;14(1):31–44.
Olmez A, Köse G, Turanli G. Cyclic vomiting with generalized epileptiform discharges responsive to topiramate therapy. Pediatr Neurol. 2006;35(5):348–51.
Chopra SS, Kulkarni SD, Hegde AU, Shah KN. Cyclical vomiting syndrome with bilateral epileptiform discharges. Indian Pediatr. 2011;48(2):143–5.
Murphy JV, Dehkharghani F. Diagnosis of childhood seizure disorders. Epilepsia. 1994;35 Suppl 2:S7–17.
Vassella F. [Differential diagnosis of cerebral seizures]. Monatsschr Kinderheilkd. 1992;140(7):391–5.
Sances G, Guaschino E, Perucca P, et al. Migralepsy: A call for revision of the definition. Epilepsia. 2009;50:2487–96.
Kossoff EH, Hatfield LA, Ball KL, et al. Comorbidity of epilepsy and headache in patients with Sturge-Weber syndrome. J Child Neurol. 2005;20:678–82.
Goh S, Butler W, Thiele EA. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology. 2004;63:1457–61.
Klopstock T, May A, Seibel P, et al. Mitochondrial DNA in migraine with aura. Neurology. 1996;46:1735–8.
Gronseth GS, Greenberg MK. The utility of the electroencephalogram in the evaluation of patients presenting with headache: A review of the literature. Neurology. 1995;45:1263–7.
Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215–24.
Hershey AD, Kabbouche MA, Powers SW. Treatment of pediatric and adolescent migraine. Pediatr Ann. 2010;39(7):416–23.
O'Brien HL, Kabbouche MA, Hershey AD. Treatment of acute migraine in the pediatric population. Curr Treat Options Neurol. 2010;12(3):178–85.
Kabbouche MA, Vockell AL, LeCates SL, Powers SW, Hershey AD. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics. 2001;107(4):E62.
Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26(5):541–6.
Larkin G. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 1999;6(6):668–70.
Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004;43(2):256–62.
Shrestha M, Singh R, Moreden J, Hayes JE. Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double blind. Arch Intern Med. 1996;156(15):1725–8.
Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache. 2000;40(9):720–3.
Tanen DA, Miller S, French T, Riffenburgh RH. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med. 2003;41(6):847–53.
Shearer P, Riviello J. Generalized convulsive status epilepticus in adults and children: treatment guidelines and protocols. Emerg Med Clin North Am. 2011;29(1):51–64.
Yamamoto LG, Yim GK. The role of intravenous valproic acid in status epilepticus. Pediatr Emerg Care. 2000;16:296–8.
Jacob J, Goadsby PJ, Duncan JS. Use of sumatriptan in postictal migraine headache. Neurology. 1996;47:1104.
Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6, CD010608.
Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15(10):1013–28.
Freitag FG. Divalproex in the treatment of migraine. Psychopharmacol Bull. 2003;37 suppl 2:98–115.
Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: Expert opinion, 2005. J Child Neurol. 2005;20 suppl 1:S1–56.
Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: A randomized controlled trial. JAMA. 2004;291:965–73.
Mathew NT, Rapoport A, Saper J, et al. Efficacy of gabapentin in migraine prophylaxis. Headache. 2001;41:119–28.
Lampl C, Katsarava Z, Diener HC, et al. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76:1730–2.
Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache. 2004;44:238–43.
Strahlman RS. Can ketosis help migraine sufferers? A case report. Headache. 2006;46:182.
Di Lorenzo C, Sirianni G, Coppola G, et al. Does migraine improve thorough ketogenic diet? Neurol Sci [Abstr]. 2010;31:S225.
Schnabel TG. An experience with a ketogenic dietary in migraine. Ann Intern Med. 1928;2:341–7.
Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia. 2005;25:82–6.
Kossoff EH, Huffman J, Turner Z, et al. Use of the modified Atkins diet for adolescents with chronic daily headache. Cephalalgia. 2010;30:1014–6.
Brna P, Dooley J, Gordon K, et al. The prognosis of childhood headache: A 20-year follow-up. Arch Pediatr Adolesc Med. 2005;159:1157–60.
Kienbacher C, Wober C, Zesch H, et al. Clinical features, classification and prognosis of migraine and tension-type headache in children and adolescents: A long-term follow-up study. Cephalalgia. 2006;26:820–30.
Shinnar S, Pellock JM. Update on the epidemiology and prognosis of pediatric epilepsy. J Child Neurol. 2002;17 Suppl 1:S4–17.
Compliance with Ethics Guidelines
ᅟ
Conflict of Interest
Dr. Christopher B. Oakley served as a consultant for the British Medical Journal and received honoraria from Southwest Florida Pediatric Conference. Dr. Oakley had travel/accommodations expenses covered or reimbursed by Southwest Florida Pediatric Conference and All Children’s Hospital-Tampa/St. Petersburg, Florida.
Dr. Eric H. Kossoff served as a consultant for Atkins Nutritionals, Inc.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Childhood and Adolescent Headache